SCHEMBL25955447

SCHEMBL25955447

Nc1ccc(N)c2c1C(=O)c1c(O)ccc(NCCOCCOS(=O)(=O)O)c1C2=O

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP19A1 P11511 1/20 0.47
▸ CSNK2A2 P19784 2/20 0.47
▸ CSNK2B P67870 2/20 0.47
▸ CSNK2A1 P68400 2/20 0.47
▸ CSNK2A3 Q8NEV1 2/20 0.47
▸ KMT2A Q03164 6/20 0.45
▸ MEN1 O00255 5/20 0.45
▸ BLM P54132 4/20 0.45
▸ SMN1; SMN2 Q16637 3/20 0.45
▸ TDP1 Q9NUW8 3/20 0.45
▸ USP2 O75604 2/20 0.45
▸ LMNA P02545 2/20 0.45
▸ TP53 P04637 2/20 0.45
▸ MAPK1 P28482 2/20 0.45
▸ RECQL P46063 2/20 0.45
▸ NPC1 O15118 2/20 0.45
▸ MTOR P42345 2/20 0.45
▸ RAB9A P51151 2/20 0.45
▸ NSD2 O96028 2/20 0.45
▸ SLC22A2 O15244 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20333876 0.85 NPC1 (0.47) CYP19A1CSNK2A2CSNK2BCSNK2A1CSNK2A3
SCHEMBL20334197 0.83 NSD2 (0.43) KMT2AMEN1BLMSMN1; SMN2TDP1
SCHEMBL3272324 0.77 CYP19A1 (0.68) CYP19A1CSNK2A2CSNK2BCSNK2A1CSNK2A3
SCHEMBL19745828 0.77 CSNK2A2 (0.61) CYP19A1CSNK2A2CSNK2BCSNK2A1CSNK2A3
SCHEMBL30544825 0.77 CYP19A1 (0.68) CYP19A1CSNK2A2CSNK2BCSNK2A1CSNK2A3
SCHEMBL9280295 0.75 CYP19A1 (0.61) CYP19A1CSNK2A2CSNK2BCSNK2A1CSNK2A3
SCHEMBL14228462 0.75 CYP19A1 (0.61) CYP19A1CSNK2A2CSNK2BCSNK2A1CSNK2A3
SCHEMBL13194388 0.75 MEN1 (0.57) CYP19A1CSNK2A2CSNK2BCSNK2A1CSNK2A3
SCHEMBL15703039 0.75 MEN1 (0.57) CYP19A1CSNK2A2CSNK2BCSNK2A1CSNK2A3
SCHEMBL10898406 0.74 CYP19A1 (0.59) CYP19A1CSNK2A2CSNK2BCSNK2A1CSNK2A3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230240954-A1 USE OF ANTHRAQUINONE DYES AND OF FLUORESCENT DYES FOR DYEING KERATIN FIBRES, DYEING PROCESS AND COMPOSITION L'OREAL (FR) 2023-08-03 — — US disclosed
US-20230240954-A1 USE OF ANTHRAQUINONE DYES AND OF FLUORESCENT DYES FOR DYEING KERATIN FIBRES, DYEING PROCESS AND COMPOSITION L'OREAL (FR) 2023-08-03 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230240954-A1 USE OF ANTHRAQUINONE DYES AND OF FLUORESCENT DYES FOR DYEING KERATIN FIBRES, DYEING PROCESS AND COMPOSITION KRT18, CUTA, KLK5 CYP19A1 1250/4885CSNK2A2 1620/4885CSNK2B 1181/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback